Literature DB >> 12403192

Causes of death and prognostic factors in Thai patients with systemic lupus erythematosus.

Nuntana Kasitanon1, Worawit Louthrenoo, Waraporn Sukitawut, Ramjai Vichainun.   

Abstract

From a cohort study of 349 Thai patients (337 females [F] and 12 males [M]) with systemic lupus erythematosus (SLE), 52 patients (51 F, 1 M) died. Their 5- and 10-year survival rates were 84.0% and 74.9%, respectively. Seventy-nine percent of deaths occurred within the first year of diagnosis. Infection contributed to 27 deaths (51.9%). The lung and the urinary system were the 2 most common sites of infection. There were 18 SLE-related deaths (34.6%), and 7 non-SLE related deaths (13.5%). In a multivariate analysis of all causes of death, serositis, hematologic abnormality, central nervous system (CNS) and renal involvement were significantly associated with poor survival, while photosensitivity and arthritis were significantly associated with longer survival. Among SLE-related death, serositis and CNS involvement were significantly associated with poor survival, and arthritis was associated with longer survival. In conclusion, infection was the most common cause of death in Thai SLE patients. CNS and visceral involvement were associated with a poor outcome.

Entities:  

Mesh:

Year:  2002        PMID: 12403192

Source DB:  PubMed          Journal:  Asian Pac J Allergy Immunol        ISSN: 0125-877X            Impact factor:   2.310


  7 in total

1.  Survival rates and risk factors for mortality in systemic lupus erythematosus patients in a Chinese center.

Authors:  Ge Wu; Xiaoyuan Jia; Dan Gao; Zhanzheng Zhao
Journal:  Clin Rheumatol       Date:  2014-05-03       Impact factor: 2.980

2.  Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system.

Authors:  Mikiko Tokunaga; Kazuyoshi Saito; Daisuke Kawabata; Yoshitaka Imura; Takao Fujii; Shingo Nakayamada; Shizuyo Tsujimura; Masao Nawata; Shigeru Iwata; Taeko Azuma; Tsuneyo Mimori; Yoshiya Tanaka
Journal:  Ann Rheum Dis       Date:  2006-11-15       Impact factor: 19.103

Review 3.  Understanding the epidemiology and progression of systemic lupus erythematosus.

Authors:  Guillermo J Pons-Estel; Graciela S Alarcón; Lacie Scofield; Leslie Reinlib; Glinda S Cooper
Journal:  Semin Arthritis Rheum       Date:  2009-01-10       Impact factor: 5.532

Review 4.  An insight into rheumatology in Thailand.

Authors:  Worawit Louthrenoo
Journal:  Nat Rev Rheumatol       Date:  2014-09-09       Impact factor: 20.543

5.  Clinicopathological Significance among Patients with In vivo Epidermal Nuclear Staining by Direct Immunofluorescence Study.

Authors:  Wararat Sirikudta; Papapit Tuchinda; Leena Chularojanamontri; Kanokvalai Kulthanan; Samruay Pinkaew
Journal:  Indian J Dermatol       Date:  2017 Mar-Apr       Impact factor: 1.494

6.  Disease characteristics and causes of early and late death in a group of Croatian patients with systemic lupus erythematosus deceased over a 10-year period.

Authors:  Ivan Padjen; Mislav Cerovec; Marijan Erceg; Miroslav Mayer; Ranko Stevanović; Branimir Anić
Journal:  Croat Med J       Date:  2018-02-28       Impact factor: 1.351

7.  Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients.

Authors:  Eleni I Kampylafka; Haralampos Alexopoulos; Michalis L Kosmidis; Demosthenes B Panagiotakos; Panayiotis G Vlachoyiannopoulos; Marinos C Dalakas; Haralampos M Moutsopoulos; Athanasios G Tzioufas
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.